CollPlant Biotechnologies Ltd (CLGN) stock

CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31Also trades as OPHI

Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026Score 9/30

$3.96+0.06 (+1.54%)

Close on Nov 11, 2026Market cap –P/E –Yield –

CollPlant Biotechnologies total debt

Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.

CollPlant Biotechnologies's total debt was $321.00K at Dec 31, 2022. For fiscal 2022 it was $321.00K, up 46.6% from the year before.

Period	Period end	Value	Change
FY2022	Dec 31, 2022	$321.00K	+46.6%
FY2021	Dec 31, 2021	$219.00K	–

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q4 FY2022	Dec 31, 2022	$321.00K	–
Q4 FY2021	Dec 31, 2021	$219.00K	–
Q2 FY2018	Jun 30, 2018	$58.00K	–

Parsed from the XBRL in CollPlant Biotechnologies's annual and quarterly filings with the SEC
Per-share figures adjusted for the 1-for-10 reverse split on Sep 4, 2026
Fourth quarters derived from the annual report minus nine months
Every figure in the statements links to its source filing